iGMDRD145
Canonical SMILES: CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O
InChI: InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1
InChI Key: HYFHYPWGAURHIV-JFIAXGOJSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameOmacetaxine mepesuccinate CHEMBLCHEMBL46286 Pubchem CID285033 DRUGBANK IDDB04865 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
AlkaloidsAngiogenesis Modulating AgentsAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntineoplastic and Immunomodulating AgentsApoptosisBenzazepinesGrowth InhibitorsGrowth SubstancesHeterocyclic CompoundsHeterocyclic Compounds with 4 or More RingsHeterocyclic Compounds, 2-RingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Omacetaxine mepesuccinate
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |